Skip to main content

Table 6 Patients experiencing AEs

From: Treatment of migraines with Tianshu capsule: a multi-center, double-blind, randomized, placebo-controlled clinical trial

Event

TSC (N = 750)

Placebo (N = 250)

P values

Adverse events, number of patients with event, no. (%)

24 (3.20%)

8 (3.20%)

1.0000

Possibly drug-related adverse events, no. (%)

9 (1.20%)

2 (0.80%)

0.7404

 gastrectasia

1 (0.13%)

0

 stomach ache

1 (0.13%)

0

 abdominal tympany

2 (0.27%)

1 (0.40%)

 dizziness

2 (0.27%)

0

 conjunctival congestion

1 (0.13%)

0

 epistaxis

1 (0.13%)

1 (0.40%)

 menometrorrhagia

1 (0.13%)

0

Adverse events resulting in experiment discontinuation, no. (%)

1 (0.10%)

1 (0.40%)

0.4377

 epigastric pain

1 (0.10%)

0

 allergy with stomach ache

0

1 (0.40%)

Serious adverse events, no. (%)

0

0

−/−